Alpha Lipoic Acid (ALA) vs Nattokinase

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Alpha Lipoic Acid (ALA)Nattokinase
CategorySupplementsSupplements
Standard Dose300-600mg R-ALA daily2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg
TimingOn empty stomach, 30-60 min before meals. Split doses for higher amounts.On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.
Cycle Durationongoing or cycle 12 weeks on, 4 weeks offongoing
Evidence Levelstrong_humanmoderate_human

Mechanism

ALA is a dithiol compound that functions as a cofactor for mitochondrial alpha-keto acid dehydrogenases (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase). Both ALA and its reduced form DHLA are potent antioxidants capable of regenerating other antioxidants including vitamin C, vitamin E, and glutathione. ALA activates AMPK, improving glucose uptake via GLUT4 translocation, and modulates NF-kB-mediated inflammatory signaling. It chelates redox-active metals (Fe2+, Cu2+).

Standard Dosing

300-600mg R-ALA daily

Timing

On empty stomach, 30-60 min before meals. Split doses for higher amounts.

Cycle Duration

ongoing or cycle 12 weeks on, 4 weeks off

Side Effects

  • GI upset/nausea
  • Skin rash
  • Hypoglycemia symptoms
  • Body odor changes

Contraindications

  • Thiamine (B1) deficiency (ALA increases thiamine demand)
  • Hypoglycemia-prone individuals without monitoring
  • Autoimmune thyroid conditions (monitor thyroid function)

Best Stacking Partners

NACCoQ10Acetyl-L-CarnitineBiotinChromium
B

Nattokinase

Supplements

Mechanism

Nattokinase is a fibrinolytic serine protease extracted from natto (fermented soybeans). It directly degrades fibrin (the structural protein of blood clots) through four mechanisms: direct fibrinolysis, enhancement of endogenous tPA (tissue plasminogen activator) production, conversion of prourokinase to urokinase, and degradation of PAI-1 (plasminogen activator inhibitor-1). It also reduces blood viscosity and may inhibit ACE (angiotensin-converting enzyme), providing mild antihypertensive effects.

Standard Dosing

2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg

Timing

On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.

Cycle Duration

ongoing

Side Effects

  • Easy bruising
  • Nosebleeds
  • GI upset
  • Rare: serious bleeding events

Contraindications

  • Active bleeding or bleeding disorders
  • Scheduled surgery (discontinue 2+ weeks prior)
  • Concurrent anticoagulant/antiplatelet therapy
  • Hemorrhagic stroke history
  • Soy allergy
  • Active bleeding
  • Bleeding disorders
  • Pre-surgery (stop 2 weeks prior)
  • Concurrent anticoagulation therapy without physician supervision

Best Stacking Partners

SerrapeptaseOmega-3Vitamin K2 (for balanced coagulation support)

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →